Claret Asset Management Corp / BMY
Claret Asset Management Corp’s Bristol-Myers Squibb Co Position
Does Claret Asset Management Corp own Bristol-Myers Squibb Co (BMY)? Yes — 189.9K shares worth $12M (+1.38% of its 13F portfolio) as of Q1 2026, up from 186.5K shares the prior filed quarter.
Position Value
$12M
Q1 2026
Shares
189.9K
% of Portfolio
+1.38%
Quarters Held
29
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 189.9K | $12M | +1.38% |
| Q4 2025 | 186.5K | $10M | +1.17% |
| Q3 2025 | 189.1K | $9M | +1.02% |
| Q2 2025 | 186.4K | $9M | +1.12% |
| Q1 2025 | 173.0K | $11M | +1.52% |
| Q4 2024 | 174.6K | $10M | +1.56% |
| Q3 2024 | 172.4K | $9M | +1.46% |
| Q2 2024 | 173.1K | $7M | +1.28% |
| Q1 2024 | 167.2K | $9M | +1.52% |
| Q4 2023 | 146.1K | $7M | +1.34% |
| Q3 2023 | 134.2K | $8M | +1.53% |
| Q2 2023 | 132.9K | $8M | +1.66% |
| Q1 2023 | 123.5K | $9M | +1.69% |
| Q4 2022 | 95.2K | $7M | +1.51% |
| Q3 2022 | 95.6K | $7M | +1.61% |
| Q2 2022 | 95.4K | $7M | +1.58% |
| Q1 2022 | 93.7K | $7M | +1.32% |
| Q4 2021 | 73.5K | $5M | +0.85% |
| Q2 2021 | 32.5K | $2M | +0.36% |
| Q1 2021 | 20.6K | $1M | +0.24% |
| Q4 2020 | 20.6K | $1M | +0.25% |
| Q3 2020 | 20.8K | $1M | +0.28% |
| Q2 2020 | 20.8K | $1M | +0.29% |
| Q1 2020 | 20.4K | $1M | +0.32% |
| Q4 2019 | 20.4K | $1M | +0.25% |
| Q3 2019 | 19.2K | $972,000 | +0.20% |
| Q2 2019 | 17.0K | $772,000 | +0.16% |
| Q1 2019 | 16.6K | $793,000 | +0.16% |
| Q4 2018 | 16.6K | $864,000 | +0.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Claret Asset Management Corp’s full portfolio or all institutional holders of BMY.